Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.12 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 11 Parkinson's trials, 1 stopped | 0.93 |
| literature PubMed | 384 Parkinson's papers of 96,440 | 0.22 |
| pathways Reactome | 6 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 2346
Sealed predictions
- CP in dopamine neurons, braak-0.11 (p 0.785) → +0.19 (p 0.630)receipt 2354
Swarm cases
receipt 2354: CP in dopamine neurons, braak
- power
- full sample +0.09 (p 0.715, n 18), 95% CI -0.39 to +0.54. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.12 (p 0.627, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.00 (p 0.990, n 18). could be the mix.
- skeptic
- leave-one-out range -0.01 to +0.26, sign flips 1; without severely affected donors +0.09 (p 0.715, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CP in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts